Explore the details of the Alexion Pharmaceuticals, Inc. V. Samsung Bioepis Co. Ltd. case under case number 1:24-cv-00005 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:24-cv-00005
Filing Date
Jan 3, 2024
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Alexion Pharmaceuticals, Inc. -
Samsung Bioepis Co. Ltd. -

Patents Involved in the Case

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jan 22, 2024SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Gerald J. Flattmann, Jr. and Andrew J. Cochran filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd. Signed by Judge Gregory B. Williams on 1/22/24. (ntl)PACER Document
Jan 23, 2024SO ORDERED, re 10 STIPULATION TO EXTEND TIME for Defendant to respond to Complaint to February 8, 2024 filed by Samsung Bioepis Co. Ltd. Signed by Judge Gregory B. Williams on 1/23/24. (ntl)PACER Document
Jan 23, 2024Pro Hac Vice Attorney Gerald J. Flattmann, Jr for Alexion Pharma International Operations Ltd.,and Alexion Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)PACER Document
Feb 8, 2024Pro Hac Vice Fee - Credit Card Payment received for Michelle S. Rhyu, Daniel J. Knauss, Orion Armon, and Jonathan Davies. ( re 13 MOTION for Pro Hac Vice Appearance of Attorney Michelle S. Rhyu, Daniel J. Knauss, Orion Armon, and Jonathan Davies )( Payment of $ 200, receipt number ADEDC-4333912).(Higgins, James) (Entered: 02/08/2024)PACER Document
Feb 9, 2024SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Michelle S. Rhyu, Daniel J. Knauss, Orion Armon, and Jonathan Davies filed by Samsung Bioepis Co. Ltd. Signed by Judge Gregory B. Williams on 2/9/24. (ntl)PACER Document
Feb 20, 2024SO ORDERED, re 26 STIPULATION TO EXTEND TIME to asnwer, move, or otherwise respond to Defendant/Counterclaim Plaintiff Samsung Bioepis Co., Ltd.'s counterclaims to March 14, 2024 filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd. Signed by Judge Gregory B. Williams on 2/20/24. (ntl)PACER Document
Feb 20, 2024Pro Hac Vice Attorney Michelle S. Rhyu for Samsung Bioepis Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)PACER Document
Feb 21, 2024Pro Hac Vice Attorneys Orion Armon and Daniel J. Knauss for Samsung Bioepis Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)PACER Document
Feb 22, 2024Pro Hac Vice Attorney Jonathan R. Davies for Samsung Bioepis Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk)PACER Document
Feb 26, 2024Pro Hac Vice Fee - Credit Card Payment received for Brianna Patterson. ( re 32 MOTION for Pro Hac Vice Appearance of Attorney Brianna Patterson )( Payment of $ 50, receipt number ADEDC-4347505).(Mayo, Andrew) (Entered: 02/26/2024)PACER Document
Feb 27, 2024SO ORDERED, re 32 MOTION for Pro Hac Vice Appearance of Attorney Brianna Patterson filed by Samsung Bioepis Co. Ltd. Signed by Judge Gregory B. Williams on 2/27/24. (ntl)PACER Document
Feb 27, 2024Pro Hac Vice Attorney Brianna Patterson for Samsung Bioepis Co. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)PACER Document
Mar 15, 2024Pro Hac Vice Attorney Andrew J. Cochran for Alexion Pharma International Operations Ltd. and Alexion Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb)PACER Document
Mar 18, 2024CORRECTING ENTRY: Corrected documents added to D.I. 20-21 per request of counsel. (ntl)PACER Document
May 10, 2024Document Unsealed -- 57 Memorandum Order. (ntl)PACER Document
May 14, 2024APPEAL - Credit Card Payment received re 58 Notice of Appeal (Federal Circuit) filed by Alexion Pharmaceuticals, Inc., Alexion Pharma International Operations Ltd.. ( Filing fee $605, receipt number ADEDC-4406805.) (Joyce, Alexandra)PACER Document
May 14, 2024Notice of Appeal and Docket Sheet to US Court of Appeals for the Federal Circuit D.I 58 Notice of Appeal (Federal Circuit). (oam)PACER Document
May 22, 2024SO ORDERED, re 64 Stipulation and Order Regarding Briefing Schedule filed by Samsung Bioepis Co. Ltd. Signed by Judge Gregory B. Williams on 5/22/2024. (lnb)PACER Document
Jun 17, 2024ORAL ORDER: The Court has reviewed Alexion's Emergency Motion for Injunction Pending Appeal (D.I. 60). The motion constitutes a motion for reconsideration with respect to the Court's prior injunction. "[T]o obtain reversal [of the denial of a preliminary injunction], the movant must show not only that one or more of the findings relied on by the district court was clearly erroneous, but also that denial of the injunction amounts to an abuse of the court's discretion upon reversal of erroneous findings." Reebok Int'l Ltd. v. J. Baker, Inc., 32 F.3d 1552, 1555 (Fed. Cir. 1994). The Court finds that Alexion has failed to show that the Court clearly erred and abused its discretion. Specifically, the Court finds that the well-reasoned IPR institution decision raises a substantial question of validity. Injunctions are an equitable remedy, and the Court will not grant an injunction on a patent likely to be invalid. See D.I. 57 at 2-5. With respect to the aHUS claim, the Court finds that it did not clearly err in finding that a person of ordinary skill in the art would "have known that SOLIRIS was clinically safe and possessed a reasonable likelihood of successfully treating aHUS by inhibiting the C5 pathway." D.I. 57 at 6. Alexion's arguments re-hash the arguments it has already made, and do not convince the Court that it has clearly erred or abused its discretion. Thus, the Court DENIES Alexion's Emergency Motion for Injunction Pending Appeal. Ordered by Judge Gregory B. Williams on 6/17/2024. (lnb) (Entered: 06/17/2024)PACER Document
Sep 3, 2024SO ORDERED, re 79 Stipulation and Order of Dismissal Without Prejudice. ***Civil Case Terminated.. Signed by Judge Gregory B. Williams on 9/3/24. (jaa)PACER Document